[#item_full_content]
Eli Lilly’s Early Alzheimer’s Treatment Donanemab Scores Japanese Approval, Its Second Largest Market
2024-09-24T13:23:52-04:00September 24th, 2024|
Related Posts
-
Novo Nordisk CEO Defends Ozempic Price In Senate Testimony
September 24th, 2024 -
Coca-Cola Spiced is being yanked after just six months
September 24th, 2024